Jolanta Widén

715 total citations
9 papers, 488 citations indexed

About

Jolanta Widén is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Spectroscopy. According to data from OpenAlex, Jolanta Widén has authored 9 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 3 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Spectroscopy. Recurrent topics in Jolanta Widén's work include Pharmacogenetics and Drug Metabolism (8 papers), Analytical Chemistry and Chromatography (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Jolanta Widén is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Analytical Chemistry and Chromatography (3 papers) and Analytical Methods in Pharmaceuticals (3 papers). Jolanta Widén collaborates with scholars based in Sweden, Finland and Canada. Jolanta Widén's co-authors include Leif Bertilsson, Gunnel Tybring, Kari Laine, Ylva Böttiger, Sebastian Härtter, Britta Ekqvist, M L Dahl, Jan‐Olof Svensson, Norio Yasui‐Furukori and Lars L. Gustafsson and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Acta Psychiatrica Scandinavica and British Journal of Clinical Pharmacology.

In The Last Decade

Jolanta Widén

9 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jolanta Widén Sweden	9	297	114	110	108	96	9	488
Steven M. Fogelman United States	9	373 1.3×	166 1.5×	152 1.4×	122 1.1×	137 1.4×	12	727
Boo Edgar Sweden	11	195 0.7×	116 1.0×	101 0.9×	60 0.6×	70 0.7×	17	508
K. Sugawara Japan	14	174 0.6×	152 1.3×	98 0.9×	121 1.1×	57 0.6×	29	537
G. Alv�n Sweden	12	304 1.0×	168 1.5×	110 1.0×	88 0.8×	102 1.1×	17	664
C. Alm Sweden	12	413 1.4×	152 1.3×	123 1.1×	185 1.7×	129 1.3×	15	764
Ya‐Qing Lou China	8	354 1.2×	108 0.9×	140 1.3×	53 0.5×	75 0.8×	24	552
Michael S. Ching Australia	18	295 1.0×	134 1.2×	170 1.5×	101 0.9×	195 2.0×	48	893
DD Breimer Netherlands	15	270 0.9×	89 0.8×	123 1.1×	74 0.7×	147 1.5×	21	689
M-L Dahl Sweden	8	409 1.4×	104 0.9×	159 1.4×	222 2.1×	123 1.3×	11	711
M L Dahl Sweden	11	445 1.5×	121 1.1×	146 1.3×	116 1.1×	90 0.9×	17	624

Countries citing papers authored by Jolanta Widén

Since Specialization

Citations

This map shows the geographic impact of Jolanta Widén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jolanta Widén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jolanta Widén more than expected).

Fields of papers citing papers by Jolanta Widén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jolanta Widén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jolanta Widén. The network helps show where Jolanta Widén may publish in the future.

Co-authorship network of co-authors of Jolanta Widén

This figure shows the co-authorship network connecting the top 25 collaborators of Jolanta Widén. A scholar is included among the top collaborators of Jolanta Widén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jolanta Widén. Jolanta Widén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Özdemir, Vural, Leif Bertilsson, Jun Miura, et al.. (2007). CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6–serotonin–dopamine crosstalk revisited. Pharmacogenetics and Genomics. 17(5). 339–347. 35 indexed citations

2.

Laine, Kari, Ümit Yaşar, Jolanta Widén, & Gunnel Tybring. (2003). A Screening Study on the Liability of Eight Different Female Sex Steroids to Inhibit CYP2C9, 2C19 and 3A4 Activities in Human Liver Microsomes. Pharmacology & Toxicology. 93(2). 77–81. 37 indexed citations

3.

Yasui‐Furukori, Norio, et al.. (2003). Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes. British Journal of Clinical Pharmacology. 56(4). 415–421. 70 indexed citations

4.

Laine, Kari, Gunnel Tybring, Sebastian Härtter, et al.. (2001). Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test. Clinical Pharmacology & Therapeutics. 70(4). 327–335. 65 indexed citations

5.

Laine, Kari, Gunnel Tybring, Sebastian Härtter, et al.. (2001). Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test.. PubMed. 70(4). 327–35. 70 indexed citations

6.

Tybring, Gunnel, et al.. (1998). High-performance liquid chromatography–mass spectrometry for the quantification of nortriptyline and 10-hydroxynortriptyline in plasma. Journal of Chromatography B Biomedical Sciences and Applications. 716(1-2). 382–386. 19 indexed citations

7.

Tybring, Gunnel, Ylva Böttiger, Jolanta Widén, & Leif Bertilsson. (1997). Enantioselective hydroxylation of omeprazole catalyzed by CYP2C19 in Swedish white subjects*. Clinical Pharmacology & Therapeutics. 62(2). 129–137. 86 indexed citations

8.

Bertilsson, Leif, Gunnel Tybring, Jolanta Widén, Ming Chang, & Torbjörn Tomson. (1997). Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19. British Journal of Clinical Pharmacology. 44(2). 186–189. 52 indexed citations

9.

Dahl, M L, Britta Ekqvist, Jolanta Widén, & Leif Bertilsson. (1991). Disposition of the neuroleptic zuclopenthixol cosegregates with the polymorphic hydroxylation of debrisoquine in humans. Acta Psychiatrica Scandinavica. 84(1). 99–102. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact